Canada markets close in 1 hour 39 minutes

Cue Biopharma Inc (1UC.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
1.71000.0000 (0.00%)
As of 08:01AM CEST. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
7,020
5,490
1,245
14,941
3,154
-
Operating Expenses
Research Development
41,610
40,802
38,578
41,347
33,546
-
Selling General and Administrative
16,690
16,680
16,169
17,307
14,651
-
Total Operating Expenses
58,300
57,482
54,747
58,653
48,197
-
Operating Income or Loss
-51,280
-51,992
-53,502
-43,712
-45,043
-
Interest Expense
1,116
1,245
713
0
-
-
Total Other Income/Expenses Net
64.078
-157
277
-
-
64.078
Income Before Tax
-49,971
-50,733
-53,010
-43,666
-44,579
-
Income Tax Expense
-
-
0
495
206.25
412.5
Income from Continuing Operations
-49,971
-50,733
-53,010
-44,161
-44,785
-
Net Income
-49,971
-50,733
-53,010
-44,161
-44,785
-
Net Income available to common shareholders
-49,971
-50,733
-53,010
-44,161
-44,785
-
Basic EPS
-1.20
-1.11
-1.49
-1.41
-1.56
-
Diluted EPS
-1.20
-1.11
-1.49
-1.41
-1.56
-
Basic Average Shares
43,751
45,755
35,649
31,285
28,689
-
Diluted Average Shares
43,751
45,755
35,649
31,285
28,689
-